Patients on Osteoporosis’ Medication May Develop Eye Disorder, Say Researchers

.

Patients on Osteoporosis’ Medication May Develop Eye Disorder, Say Researchers

For the very first time, a study has showed that patients on osteoporosis’ medication are at a higher risk of being affected with inflammatory eye disease. The study was conducted by the researchers of Child and Family Research Institute located in Vancouver.

During the study, the researchers examined the effect of osteoporosis’ medication, oral bisphosphonates over eye conditions uveitis and scleritis. During the study, it was found that the patients on bisphosphonates were at higher risk of developing the eye disorders.

The findings of the study have been published in the journal Canadian Medical Association. For the study, the researchers analyzed the data of 934,147 patients. The majority of the patients were not taking the bisphosphonates.

The researchers informed that patients who had been taking bisphosphonates for the very first time were more likely to be affected with uveitis and scleritis. The author of the study noted, “Our study highlights the need for clinicians to inform their patients about the signs and symptoms of scleritis and uveitis, so that prompt treatment may be sought and further complications averted”.

The findings have stirred unrest among the health experts, as it is for the very first time when a study has showed that the osteoporosis’ medication can have adverse outcomes on the health of the patients.


Latest News

Report Shows Large Number of Americans still Prefer Receiving Credit Card Statem
U.S. Big Banks Pass Annual Stress Test
Viacom’s Board will Remain as it is for the Time being, Judge Sets Hearing for J
Crude Stockpiles Drop in the U. S
A New Study Highlights that U. S. Expected to Spend $2.6 Trillion Less than Esti
SolarCity Shares Soar with Tesla's Bid for the Company
The Leave as well as Remain Camps Gathers Pace in Brexit
Oil’s Advance Halts as Market Awaits U.S Stock Pile Data and Brexit Poll
Martin Winterkorn and a Current VW Board Member Under Investigation by Prosecuto
Survey Shows Some Workplace Benefits are Fading with Time
Kimco Realty Corporation Shares Climbed 0.21 Percent Last Week
Sluggish Growth and Inflation is Taking More Time Than Expected Affecting Fed’s